Cargando…
Patient-specific organotypic blood vessels as an in vitro model for anti-angiogenic drug response testing in renal cell carcinoma
BACKGROUND: Anti-angiogenic treatment failure is often attributed to drug resistance, unsuccessful drug delivery, and tumor heterogeneity. Recent studies have speculated that anti-angiogenic treatments may fail due to characteristics inherent to tumor-associated blood vessels. Tumor-associated blood...
Autores principales: | Jiménez-Torres, José A., Virumbrales-Muñoz, María, Sung, Kyung E., Lee, Moon Hee, Abel, E. Jason, Beebe, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491391/ https://www.ncbi.nlm.nih.gov/pubmed/30902740 http://dx.doi.org/10.1016/j.ebiom.2019.03.026 |
Ejemplares similares
-
Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics
por: Shapiro, Daniel D., et al.
Publicado: (2022) -
Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure
por: Bischel, Lauren L, et al.
Publicado: (2015) -
Primary Head and Neck Tumour-Derived Fibroblasts Promote Lymphangiogenesis in a Lymphatic Organotypic Co-culture Model
por: Lugo-Cintrón, Karina M., et al.
Publicado: (2021) -
The SUMO protease SENP1 promotes aggressive behaviors of high HIF2α expressing renal cell carcinoma cells
por: Lee, Moon Hee, et al.
Publicado: (2022) -
Toward improved in vitro models of human cancer
por: Ayuso, Jose M., et al.
Publicado: (2021)